A relaxed man in his late 50s outdoors in a British park

Prostate Cancer Screening Is Getting Smarter: What Men Over 50 Should Know

For many years, prostate cancer screening has been surrounded by mixed messages. The good news is that screening is now becoming more accurate, more personalised, and less likely to send men straight into unnecessary biopsies after a single raised PSA result (Prostate Cancer UK, European Association of Urology).

Medical note: This article is educational and is not a diagnosis or a treatment plan. Decisions about PSA testing, scans, and biopsies should always be made with your GP or a specialist, who can weigh your age, family history, and overall health.

Why screening matters

Prostate cancer is one of the most common cancers in men, and age is the biggest risk factor, which is why conversations about screening become especially relevant from around age 50. Screening does not diagnose cancer by itself, but it can help identify men who may benefit from further checks before symptoms appear (Memorial Sloan Kettering Cancer Center).

The main screening test is still the PSA blood test, which measures prostate-specific antigen, a protein made by the prostate gland. PSA can rise because of prostate cancer, but it can also rise because of benign enlargement, inflammation, infection, recent ejaculation, cycling, or medical procedures, so one raised result does not automatically mean cancer (CDC, US Preventive Services Task Force).

The PSA test today

The PSA test remains the first step in the prostate cancer diagnostic pathway because it is simple, safe, widely available, and useful for identifying men who may need further assessment. In the UK, recent expert consensus states that informed men should be able to access PSA testing from age 50, while men at higher-than-average risk should have discussions earlier, from around age 45 (Prostate Cancer UK).

Higher-risk groups include Black men, men with a family history of prostate cancer, and men with confirmed genetic risk factors such as a BRCA2 gene variation. The UK National Screening Committee has also recommended a targeted PSA screening programme every two years for men aged 45 to 61 who have a pathogenic BRCA2 variant plus a family history of breast, ovarian, pancreatic, or prostate cancer (Cancer Research UK).

What has improved

The biggest change is that a raised PSA is no longer usually treated as an automatic route to biopsy. Modern pathways often use repeat PSA testing, risk assessment, MRI scans, PSA density, and sometimes newer biomarker tests to decide who really needs a biopsy (European Association of Urology).

Multiparametric MRI is one of the most important advances because it can show suspicious areas inside the prostate and help doctors target biopsies more accurately. European guidance now recommends using MRI to help avoid unnecessary biopsies, and when a biopsy is needed, a combination of targeted and regional sampling is advised (European Association of Urology).

A GP discussing prostate cancer screening options with an older male patient

MRI and biomarkers

MRI can help separate men who need urgent investigation from those who may be safely monitored. A UK screening trial suggested that combining MRI with PSA density may improve detection of clinically significant prostate cancer while keeping overdiagnosis of low-risk disease very low (ecancer).

New urine and blood biomarker tests are also being developed to improve decision-making after a raised PSA. For example, the MyProstateScore 2.0 urine test looks at 18 genetic markers linked with clinically significant prostate cancer and, in validation research, showed high sensitivity and negative predictive value for the more important cancers, with estimates that around 40% of unnecessary biopsies could be avoided (National Cancer Institute).

What this means for you

For men over 50, the message is not “ignore PSA” or “panic about PSA.” The better message is this: use PSA as the starting point, then make decisions with your doctor using the full picture — age, family history, ethnicity, symptoms, repeat PSA results, MRI findings, and overall health (Memorial Sloan Kettering Cancer Center).

If your PSA is raised, ask your GP or specialist whether it should be repeated, whether an MRI is appropriate, and whether PSA density or a biomarker test could help clarify your risk before biopsy. If cancer is found, not every case needs immediate treatment, because active surveillance is considered appropriate for many men with low-risk prostate cancer (European Association of Urology).

A practical checklist

  • If you are 50 or older, consider asking your GP about the pros and cons of a PSA test.
  • If you are Black, have a close family history of prostate cancer, or carry a BRCA2 gene variation, consider starting the conversation from age 45.
  • Do not assume one raised PSA means cancer; ask whether the test should be repeated and whether infection or other temporary causes could be involved.
  • If PSA remains raised, ask whether an MRI is the next step before biopsy.
  • If MRI is unclear or biopsy decisions are uncertain, ask whether a biomarker test may help refine the decision.
  • If low-risk prostate cancer is diagnosed, ask whether active surveillance is suitable before deciding on treatment.

Prostate cancer screening is not perfect, but it is improving quickly. Today, men have a better chance of finding serious cancer early while reducing the risk of unnecessary biopsies, overdiagnosis, and treatment for cancers that may never have caused harm.

The bigger picture: staying proactive after 50

Screening is one part of a wider habit that serves men well in later life: paying attention, asking questions, and not putting off the conversations that matter. The men who do best tend to be the ones who stay engaged with their health rather than waiting for something to go wrong — booking the check-up, knowing their family history, and keeping up the everyday routines that support general wellbeing.

Swiss BioEnergetics perspective: Staying proactive about men’s health after 50 is a habit worth keeping — regular check-ups, an honest picture of your family history, and the simple daily routines you can stick to. Among the botanicals many UK men over 50 choose to keep in their daily routine is saw palmetto, a traditional berry extract long popular with men in this age group. As with any supplement, it is a complement to good habits and regular medical care, never a replacement for them.

This article is provided for general information and education only. It is not medical advice and should not be used to diagnose or treat any condition. Food supplements are not intended to diagnose, treat, cure, or prevent any disease, and should not replace a varied, balanced diet or a healthy lifestyle. Always speak with your GP or a qualified healthcare professional about PSA testing and any concerns regarding prostate health.

Back to blog